Abstract:Background Lack of appropriate tools and techniques to study fate and functional integration of newly generated neurons has so far hindered understanding of neurogenesis' relevance under physiological and pathological conditions. Current analyses are either dependent on mitotic labeling, for example BrdU-incorporation or retroviral infection, or on the detection of transient immature neuronal markers. Here, we report a transgenic mouse model (DCX-CreERT2) for time-resolved fate analysis of newly generated neurons. This model is based on the expression of a tamoxifen-inducible Cre recombinase under the control of a doublecortin (DCX) promoter, which is specific for immature neuronal cells in the CNS. Results In the DCX-CreERT2 transgenic mice, expression of CreERT2 was restricted to DCX+ cells. In the CNS of transgenic embryos and adult DCX-CreERT2 mice, tamoxifen administration caused the transient translocation of CreERT2 to the nucleus, allowing for the recombination of loxP-flanked sequences. In our system, tamoxifen administration at E14.5 resulted in reporter gene activation throughout the developing CNS of transgenic embryos. In the adult CNS, neurogenic regions were the primary sites of tamoxifen-induced reporter gene activation. In addition, reporter expression could also be detected outside of neurogenic regions in cells physiologically expressing DCX (e.g. piriform cortex, corpus callosum, hypothalamus). Four weeks after recombination, the vast majority of reporter-expressing cells were found to co-express NeuN, revealing the neuronal fate of DCX+ cells upon maturation. Conclusions This first validation demonstrates that our new DCX-CreERT2 transgenic mouse model constitutes a powerful tool to investigate neurogenesis, migration and their long-term fate of neuronal precursors. Moreover, it allows for a targeted activation or deletion of specific genes in neuronal precursors and will thereby contribute to unravel the molecular mechanisms controlling neurogenesis.

Conditional gene expression systems in the transgenic rat brain

Tissue Specific Expression of Cre in Rat Tyrosine Hydroxylase and Dopamine Active Transporter-Positive Neurons

Conditional Gene Expression and Targeting in Neuroscience Research.

Advanced genetic and viral methods for labelling and manipulation of oxytocin and vasopressin neurones in rats

Retake the center stage--new development of rat genetics.

Using Conditional Mutagenesis To Study The Brain

Conditional control of gene expression in the mouse

Catecholaminergic cell type-specific expression of Cre recombinase in knock-in transgenic rats generated by the Combi-CRISPR technology

A Cre-Dependent CRISPR/dCas9 System for Gene Expression Regulation in Neurons

Cell-specific expression of Cre recombinase in rat noradrenergic neurons via CRISPR-Cas9 system

Gene Editing in Rat Embryonic Stem Cells to Produce In Vitro Models and In Vivo Reporters

Heritable and inducible gene knockdown in astrocytes or neurons in vivo by a combined lentiviral and RNAi approach

Stable, neuron-specific gene expression in the mouse brain

A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation

Conditional gene expression in the respiratory epithelium of the mouse

Using reporter genes to label selected neuronal populations in transgenic mice for gene promoter, anatomical, and physiological studies

CRISPR/Cas9-mediated targeting of the Rosa26 locus produces Cre reporter rat strains for monitoring Cre/loxP-mediated lineage tracing.

A Powerful Transgenic Tool for Fate Mapping and Functional Analysis of Newly Generated Neurons

Generation of site-specific mutations in the rat genome via CRISPR/Cas9.

An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression

Next Generation Transgenic Rat Model Production